Theodor Dingermann (Editor)
Faculty of Biochemistry Institute for Pharmaceutical Biology Goethe-University Frankfurt Frankfurt, Germany. Theodor Dingermann (1948) studied pharmacy at the University of Erlangen- Nurnberg between 1973 and 1976. In 1980, he received his Ph.D. in biochemistry. From 1980 to 1982, he worked as a postdoctoral fellow at Yale University, New Haven, USA, with Prof. Dr. Dieter Söll. From 1990 to 2013, he was a Professor and Director of the Department of Pharmaceutical Biology at Goethe University Frank- furt/Main. Since 2013, he has been affiliated with the Goethe University as a Senior Professor. Prof. Dingermann received the Carl-Mannich-Medal Award from the German Pharmaceutical Society in 2010, and he was elected “Professor of the Year 2009” in Germany. He is editor-in-chief of the international scientific journal DIE PHARMAZIE, editor-in-chief of Pharmakon, the official journal of the German Pharmaceutical Society, and a member of the group of chief editors of the Pharmazeutische Zeitung. Between 2005 and 2014, Prof. Dingermann was the Representative for Biotech- nology for the State of Hessen. He is an elected member of the German Pharmaceu- tical Association’s Drug Commission (Arzneimittelkommission der Deutschen Apothekerschaft) and since 1992 has been Chairman of the working group “recom- binant DNA products” of the German Pharmacopoeia committee at the BfArM. From 1996 to 2000, he was Vice President and from 2000 to 2004 President of the German Pharmaceutical Society (DPhG). From 1998 to 2000, he served as Vice President of Goethe University Frankfurt/Main. At GBS, Prof. Dr. Dingermann is the Academic Director of the Master of Pharma Business Administration. He is in great demand as a speaker at international events and author of numerous publications.Faculty of Biochemistry Institute for Pharmaceutical Biology Goethe-University Frankfurt Frankfurt, Germany. Theodor Dingermann (1948) studied pharmacy at the University of Erlangen- Nurnberg between 1973 and 1976. In 1980, he received his Ph.D. in biochemistry. From 1980 to 1982, he worked as a postdoctoral fellow at Yale University, New Haven, USA, with Prof. Dr. Dieter Söll. From 1990 to 2013, he was a Professor and Director of the Department of Pharmaceutical Biology at Goethe University Frank- furt/Main. Since 2013, he has been affiliated with the Goethe University as a Senior Professor. Prof. Dingermann received the Carl-Mannich-Medal Award from the German Pharmaceutical Society in 2010, and he was elected “Professor of the Year 2009” in Germany. He is editor-in-chief of the international scientific journal DIE PHARMAZIE, editor-in-chief of Pharmakon, the official journal of the German Pharmaceutical Society, and a member of the group of chief editors of the Pharmazeutische Zeitung. Between 2005 and 2014, Prof. Dingermann was the Representative for Biotech- nology for the State of Hessen. He is an elected member of the German Pharmaceu- tical Association’s Drug Commission (Arzneimittelkommission der Deutschen Apothekerschaft) and since 1992 has been Chairman of the working group “recom- binant DNA products” of the German Pharmacopoeia committee at the BfArM. From 1996 to 2000, he was Vice President and from 2000 to 2004 President of the German Pharmaceutical Society (DPhG). From 1998 to 2000, he served as Vice President of Goethe University Frankfurt/Main. At GBS, Prof. Dr. Dingermann is the Academic Director of the Master of Pharma Business Administration. He is in great demand as a speaker at international events and author of numerous publications.
En çok satan kitaplar
Aynı yazar tarafından yazılan bu kitaplara da ilgi duyabilirsiniz.
Faculty of Biochemistry Institute for Pharmaceutical Biology Goethe-University Frankfurt Frankfurt, Germany. Theodor Dingermann (1948) studied pharmacy at the University of Erlangen- Nurnberg between 1973 and 1976. In 1980, he received his Ph.D. in biochemistry. From 1980 to 1982, he worked as a postdoctoral fellow at Yale University, New Haven, USA, with Prof. Dr. Dieter Söll. From 1990 to 2013, he was a Professor and Director of the Department of Pharmaceutical Biology at Goethe University Frank- furt/Main. Since 2013, he has been affiliated with the Goethe University as a Senior Professor. Prof. Dingermann received the Carl-Mannich-Medal Award from the German Pharmaceutical Society in 2010, and he was elected “Professor of the Year 2009” in Germany. He is editor-in-chief of the international scientific journal DIE PHARMAZIE, editor-in-chief of Pharmakon, the official journal of the German Pharmaceutical Society, and a member of the group of chief editors of the Pharmazeutische Zeitung. Between 2005 and 2014, Prof. Dingermann was the Representative for Biotech- nology for the State of Hessen. He is an elected member of the German Pharmaceu- tical Association’s Drug Commission (Arzneimittelkommission der Deutschen Apothekerschaft) and since 1992 has been Chairman of the working group “recom- binant DNA products” of the German Pharmacopoeia committee at the BfArM. From 1996 to 2000, he was Vice President and from 2000 to 2004 President of the German Pharmaceutical Society (DPhG). From 1998 to 2000, he served as Vice President of Goethe University Frankfurt/Main. At GBS, Prof. Dr. Dingermann is the Academic Director of the Master of Pharma Business Administration. He is in great demand as a speaker at international events and author of numerous publications.
En popüler
Advances in Pharma Business Management and Research
This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and Sustainable Actions to Improve Employee's Engagement', 'Global Medical Clinical and Regulatory Affairs (GMCRA)', and 'A Quality Management System for R&D Project and Portfolio Management in a Pharmaceutical Company'. The chapters are summaries of master’s theses by "high potential" Pharma MBA students from the Goethe Business School, Frankfurt/Main, Germany, with 8-10 years of work experience and are based on scientific know-how and real-world experience. The authors applied their interdisciplinary knowledge gained in 22 months of studies in the MBA program to selected practical themes drawn from their daily business.
